Find Research Projects

Search results

• A Phase 1/2, First-Time-in Human (FTiH), randomized, observer-blind, placebo-controlled, dose escalation study to assess safety, reactogenicity and immunogenicity of a candidate cytomegalovirus (CMV) vaccine comprising recombinant protein and adjuvant wh

  Rupp, R.

  11/12/21 → 11/11/26

  Project: Other project

• A PHASE 1, SINGLE-ASCENDING DOSE, MULTIPLE-ASCENDING DOSE, AND MULTI DOSE SAFETY, TOLERABILITY, PHARAMCOKINETICS, AND PHARACODYNAMICS STUDY OF SUBCUTANEOUSLY ADMINISTERED ALN-AS1 IN PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP)

  Anderson, K.

  1/22/16 → 1/21/19

  Project: Other project

• A PHASE 1, SINGLE-ASCENDING DOSE, MULTIPLE-ASCENDING DOSE, AND MULTI DOSE SAFETY, TOLERABILITY, PHARAMCOKINETICS, AND PHARACODYNAMICS STUDY OF SUBCUTANEOUSLY ADMINISTERED ALN-AS1 IN PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP)

  Anderson, K.

  1/22/16 → 1/21/19

  Project: Other project

• A Phase 1, Randomized, Single Dose, Blinded, Dose-Escalation Study to Assess Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

  Rupp, R.

  Astellas Pharma Global Development Inc

  6/19/20 → 6/18/23

  Project: Other project

• A Phase 1, Randomized, Single Dose, Blinded, Dose-Escalation Study to Assess Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

  Rupp, R.

  6/19/20 → 6/18/23

  Project: Other project

• A Phase 1,Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment for Bacterial Infections¿

  Aigbivbalu, L.

  11/13/13 → 11/12/15

  Project: Other project

• A Phase 1,Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment for Bacterial Infections¿

  Aigbivbalu, L.

  11/13/13 → 11/12/15

  Project: Other project

• Antiviral therapies against re-emerging pathogens

  Paessler, S.

  2/1/15 → 12/31/16

  Project: Other project

• Antiviral therapies against re-emerging pathogens

  Paessler, S.

  2/1/15 → 12/31/16

  Project: Other project

• Antiviral Testing of Inhibitors of SARS-CoV-2

  Shi, P.

  Aligos Therapeutics Inc

  12/1/20 → 6/30/21

  Project: Other project

• Antivirals against Lassa (Sponsored Programs Contract)

  Paessler, S.

  11/1/18 → 10/31/19

  Project: Other project

• Antivirals against Lassa (Sponsored Programs Contract)

  Paessler, S.

  11/1/18 → 10/31/19

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Weaver, S.

  3/1/15 → 2/15/16

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Weaver, S.

  VenatoRx Pharmaceuticals, Inc.

  3/1/15 → 2/15/16

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Aguilar, P.

  12/1/17 → 7/31/19

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Aguilar, P.

  12/1/17 → 7/31/19

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Weaver, S.

  3/1/15 → 2/15/16

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Weaver, S.

  3/1/15 → 2/15/16

  Project: Other project

• Antiviral Efficacy Assessment of Arbutus Compounds in a SARS CoV-2 Hamster Infection Model

  Geisbert, T.

  6/1/21 → 5/31/23

  Project: Other project

• Antiviral Efficacy Assessment of Arbutus Compounds in a SARS CoV-2 Hamster Infection Model

  Geisbert, T.

  6/1/21 → 5/31/23

  Project: Other project

• Antiviral Drug Testing and Resistance Selection

  Shi, P.

  2/1/21 → 10/31/21

  Project: Other project

• Antiviral Drug Testing and Resistance Selection

  Shi, P.

  Atea Pharmaceuticals Incorporated

  2/1/21 → 10/31/21

  Project: Other project

• Antiviral Activity Testing of NeutroPhase Against Ebola Virus

  Freiberg, A.

  5/15/15 → 7/31/15

  Project: Other project

• Antiviral Activity Testing of NeutroPhase Against Ebola Virus

  Freiberg, A.

  5/15/15 → 7/31/15

  Project: Other project

• Antithrombin III (AT) Activity in Women with Severe Preeclampsia (PE) or Superimposed PE prior to 31 weeks

  Saade, G.

  9/14/19 → 10/10/21

  Project: Other project

• Antithrombin III (AT) Activity in Women with Severe Preeclampsia (PE) or Superimposed PE prior to 31 weeks

  Saade, G.

  9/14/19 → 7/31/22

  Project: Other project

• Antithrombin III (AT) Activity in Women with Severe Preeclampsia (PE) or Superimposed PE prior to 31 weeks

  Saade, G.

  9/14/19 → 7/31/22

  Project: Other project

• Anti-SARS-CoV-2 activities of compounds (Oregon Health & Science University)

  Huang, C.

  4/23/20 → 10/22/20

  Project: Other project

• Anti-SARS-CoV-2 activities of compounds (Oregon Health & Science University)

  Huang, C.

  Oregon Health Sciences University

  4/23/20 → 10/22/20

  Project: Other project

• Antiretroviral Therapy and Neuroinflammation in the CNS

  Tang, S.

  9/30/16 → 7/31/21

  Project: Other project

• Antiretroviral Therapy and Neuroinflammation in the CNS

  Chung, J.

  9/30/16 → 7/31/22

  Project: Other project

• Antimicrobial Dressing versus Standard Dressing in Obese Women Undergoing Cesarean Delivery: A Pilot Study

  Saad, A.

  12/5/18 → 12/4/20

  Project: Other project

• Antimicrobial Dressing versus Standard Dressing in Obese Women Undergoing Cesarean Delivery: A Pilot Study

  Saad, A.

  12/5/18 → 12/4/20

  Project: Other project

• Antibody therapeutics for human viral hemorrhagic fevers and prevention of late neurological syndromes

  Paessler, S.

  9/22/16 → 8/31/17

  Project: Other project

• Antibody therapeutics for human viral hemorrhagic fevers and prevention of late neurological syndromes

  Paessler, S.

  9/22/16 → 8/31/17

  Project: Other project

• Antibiotic Safety in Infants with Complicated Intra-Abdominal Infections

  Shattuck, K.

  3/27/14 → 9/23/17

  Project: Other project

• Antibiotic Safety in Infants with Complicated Intra-Abdominal Infections

  Shattuck, K.

  3/27/14 → 9/23/17

  Project: Other project

• Anterior Pituitary Dsyfunction and TBI

  Urban, R.

  4/3/12 → 4/2/17

  Project: Other project

• Anterior Pituitary Dsyfunction and TBI

  Urban, R.

  4/3/12 → 4/2/17

  Project: Other project

• A Novel System Using Human Fetal Brain Neural Stem Cell To Model ZIKV Infection

  Wu, P.

  5/1/16 → 8/31/16

  Project: Other project

• A Novel System Using Human Fetal Brain Neural Stem Cell to Model ZIKV Infection

  Wu, P.

  11/9/16 → 4/30/19

  Project: Other project

• A Novel System Using Human Fetal Brain Neural Stem Cell to Model ZIKV Infection

  Wu, P.

  11/9/16 → 4/30/19

  Project: Other project

• A Novel Paradigm for Aryl Hydrocarbon Receptor Signaling

  Elferink, C.

  5/1/15 → 4/30/18

  Project: Other project

• A Novel Paradigm for Aryl Hydrocarbon Receptor Signaling

  Elferink, C.

  5/1/15 → 4/30/18

  Project: Other project

• A novel field-applicable molecular test for visceral leishmaniasis

  Travi, B.

  8/1/15 → 7/31/18

  Project: Other project

• A novel field-applicable molecular test for visceral leishmaniasis

  Travi, B.

  8/1/15 → 7/31/18

  Project: Other project

• A novel field-applicable molecular test for visceral leishmaniasis

  Travi, B.

  8/1/15 → 7/31/18

  Project: Other project

• A novel field-applicable molecular test for visceral leishmaniasis

  Travi, B.

  8/1/15 → 7/31/18

  Project: Other project

• A novel field-applicable molecular test for visceral leishmaniasis

  Travi, B.

  National Inst of Allergy & Infectious Di

  8/1/15 → 7/31/18

  Project: Other project

• A novel field-applicable molecular test for visceral leishmaniasis

  Travi, B.

  National Inst of Allergy & Infectious Di

  8/1/15 → 7/31/18

  Project: Other project